Literature DB >> 3405031

[Hearing screening in neonates and infants using brain stem evoked acoustic potentials].

H von Wedel1, U Schauseil-Zipf, W H Döring.   

Abstract

Reported failure rates of screening using the conventional brainstem auditory response (BAER), audiometry range from 5% to 60% with about 30% of the babies having normal hearing sensitivity on follow-up. The results of testing by an automated infant screener using advanced evoked response technology are compared with those of a conventional evoked response system operated by skilled personnel. 50 newborn were tested at a gestational age of 40-42 weeks. Normal results were obtained in all 25 newborn (50 ears) of the control group using both testing procedures. Out of 25 newborn (50 ears) at risk for congenital perinatal or postnatal hearing disorder, abnormal results for either screening or conventional BAER recording were seen in 6 ears with both methods.

Entities:  

Mesh:

Year:  1988        PMID: 3405031

Source DB:  PubMed          Journal:  Laryngol Rhinol Otol (Stuttg)        ISSN: 0340-1588


  4 in total

1.  Maturation of binaural interaction components in auditory brainstem responses of young guinea pigs with monaural or binaural conductive hearing loss.

Authors:  M Laska; M Walger; I Schneider; H von Wedel
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  Maturation of auditory evoked potentials in young guinea pigs with binaural conductive hearing loss.

Authors:  M Walger; M Laska; I Schneider; H Diekmann; H von Wedel
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

3.  Evaluation of otoacoustic emissions in high-risk infants by using an easy and rapid objective auditory screening method.

Authors:  P K Plinkert; G Sesterhenn; R Arold; H P Zenner
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

Review 4.  Otoacoustic emissions: a new method to diagnose hearing impairment in children.

Authors:  P G Zorowka
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.